- Duration (years): 3 semesters
- Qualification Awarded: Master of Science in Inherited Hemoglobin Disorders: Thalassaemia and Sickle Cell Syndromes
- Level of Qualification: Master Degree (2nd Cycle)
- Language of Instruction: English
- Mode of Study: Distance Learning
- Minimum Credits: 27
- Minimum ECTS Credits: 90
Profile of the Programme:
- To increase access of quality health care to patients with haemoglobin disorders: thalassaemia and sickle cell syndromes globally consequent to strengthening the education, training and skills of medical specialists in the control and treatment of inherited haemoglobin disorders;
- To support the development of effective control strategies, that is prevention and treatment globally.
- To develop an educational programme at the postgraduate level of Master of Science to cover the holistic care of haemoglobin disorders addressed to medical specialists globally;
- To utilize the knowledge, experience, expertise of a diverse range of medical and scientific disciplines from the different parts of the world, particularly Europe, where successful control programmes have been established and where wide research programmes have been conducted for developing the programme curriculum;
- To bring the control of haemoglobin disorders, including the components of prevention and treatment, to the forefront of the agendas of health authorities at the national level and the regional and international level including official bodies such as the World Health Organisation (WHO) and the European Union (EU), and support their integration into established official programmes including non-communicable diseases or prevention of birth defects programmes or rare diseases programmes in Europe;
- To bring to the forefront of the agendas of professional health bodies, industry and research the needs to allocate more resources and focus on further improvement in the care and total cure mainly of these diseases;
- The components of prevention and management of these diseases constitute an example for building up and constructing control programmes for other genetic diseases.
There has been a long term request from many countries around the world on the needs of education of medical specialists in the field to allow the promotion of these disorders on the national health agendas and on the guidance of policy makers at the national level to develop appropriate programmes. Therefore, graduates of this program would have employment opportunities in universities, specialized health centers, government health offices, in national associations and in international offices promoting worldwide health (such as the WHO or international associations).
Access to Further Studies:
Graduates of the programme can be accepted into Second Cycle degrees (Master’s Degree)
The student must complete 90 ECTS and all programme requirements.
A minimum cumulative grade point average (CPA) of 2.0 is required. Thus, although a ‘D-‘ is a PASS grade, in order to achieve a CPA of 2.0 an average grade of ‘C’ is required.
Upon successful completion of this program, the students should be
- Able to acquire in-depth knowledge on how to treat patients with haemoglobin disorders with confidence;
- Able to fully understand the genetics and pathophysiology as well as the natural history of these disorders in order to achieve the best possible outcomes;
- Confident in the interpretation of laboratory, radiological and other results both for the purposes of accurate diagnosis but also for the follow up of patients under treatment;
- Able to evaluate the impact of the inherited haemoglobin disorders on the economical and public health aspects, understand their social repercussions and promote effective control programmes including effective prevention and appropriate clinical management;
- Able to work, collaborate closely and guide policy makers on developing effective control programmes and with official bodies, including WHO and the EU, in promoting the implementation of the specific resolutions adopted by World Health Assembly (WHA) in 2006 and the Recommendation of 2011 by the EU, to Member States and/or their integration into their established programmes of non-communicable diseases or prevention of birth defects or rare diseases programmes.
This school offers programs in:
Last updated May 15, 2017